Comment les DAPK affectent-elles la réponse au traitement ?
Des DAPK dysfonctionnelles peuvent réduire l'efficacité des traitements anticancéreux.
Réponse au traitementTraitements anticancéreux
#4
Les DAPK influencent-elles la résistance aux médicaments ?
Oui, des altérations des DAPK peuvent contribuer à la résistance aux médicaments anticancéreux.
Résistance aux médicamentsMédicaments anticancéreux
#5
Y a-t-il des complications liées à la neurodégénérescence ?
Oui, des DAPK mal régulées peuvent aggraver les maladies neurodégénératives.
NeurodégénérescenceMaladies neurodégénératives
Facteurs de risque
5
#1
Quels facteurs génétiques influencent les DAPK ?
Des mutations dans les gènes DAPK peuvent augmenter le risque de cancer.
Facteurs génétiquesMutations
#2
L'âge est-il un facteur de risque pour les DAPK ?
Oui, le vieillissement peut affecter l'expression et la fonction des DAPK.
ÂgeVieillissement
#3
Le tabagisme influence-t-il les DAPK ?
Oui, le tabagisme peut altérer l'expression des DAPK et augmenter le risque de cancer.
TabagismeCancer
#4
Y a-t-il des facteurs hormonaux affectant les DAPK ?
Oui, des déséquilibres hormonaux peuvent influencer l'activité des DAPK.
Facteurs hormonauxDéséquilibres hormonaux
#5
L'exposition à des produits chimiques est-elle un risque ?
Oui, l'exposition à des agents cancérigènes peut affecter les DAPK et augmenter le risque de cancer.
Produits chimiquesAgents cancérigènes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Death-associated protein kinases : Questions médicales les plus fréquentes",
"headline": "Death-associated protein kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Death-associated protein kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-07",
"dateModified": "2026-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Death-associated protein kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Calcium-Calmodulin-Dependent Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D017871",
"about": {
"@type": "MedicalCondition",
"name": "Calcium-Calmodulin-Dependent Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017871",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.125"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Death-associated protein kinases",
"alternateName": "Death-Associated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D064550",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tae Ho Lee",
"url": "https://questionsmedicales.fr/author/Tae%20Ho%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China. leethres@hotmail.com."
}
},
{
"@type": "Person",
"name": "Dongmei Chen",
"url": "https://questionsmedicales.fr/author/Dongmei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China."
}
},
{
"@type": "Person",
"name": "Tao Zhang",
"url": "https://questionsmedicales.fr/author/Tao%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China."
}
},
{
"@type": "Person",
"name": "Long Wang",
"url": "https://questionsmedicales.fr/author/Long%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China."
}
},
{
"@type": "Person",
"name": "Xindong Shui",
"url": "https://questionsmedicales.fr/author/Xindong%20Shui",
"affiliation": {
"@type": "Organization",
"name": "Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Role of Death-Associated Protein Kinase-1 in Cell Homeostasis-Related Processes.",
"datePublished": "2023-06-16",
"url": "https://questionsmedicales.fr/article/37372454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes14061274"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of the molecular interactions between resveratrol derivatives and death-associated protein kinase 1.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37171222",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/febs.16817"
}
},
{
"@type": "ScholarlyArticle",
"name": "Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.",
"datePublished": "2024-05-24",
"url": "https://questionsmedicales.fr/article/38787485",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-024-09240-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long non-coding RNA nuclear paraspeckle assembly transcript 1 downregulation protects lens epithelial cells from oxidative stress-induced apoptosis by regulating the microRNA-124-3p/death-associated protein kinase 1 axis in age-related cataract.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37191928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02749-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.",
"datePublished": "2024-01-09",
"url": "https://questionsmedicales.fr/article/38195518",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40035-023-00395-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Calcium-Calmodulin-Dependent Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017871"
},
{
"@type": "ListItem",
"position": 7,
"name": "Death-associated protein kinases",
"item": "https://questionsmedicales.fr/mesh/D064550"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Death-associated protein kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Death-associated protein kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Death-associated protein kinases",
"description": "Comment diagnostiquer une dysrégulation des DAPK ?\nQuels marqueurs sont associés aux DAPK ?\nLes DAPK sont-elles liées à des maladies spécifiques ?\nQuels tests sont utilisés pour évaluer l'activité des DAPK ?\nPeut-on détecter les DAPK dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D064550#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Death-associated protein kinases",
"description": "Quels symptômes sont liés à une suractivation des DAPK ?\nLes DAPK affectent-elles le système immunitaire ?\nY a-t-il des symptômes neurologiques associés aux DAPK ?\nLes DAPK sont-elles impliquées dans la douleur ?\nQuels effets sur la croissance cellulaire sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D064550#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Death-associated protein kinases",
"description": "Peut-on prévenir les dysfonctionnements des DAPK ?\nY a-t-il des facteurs environnementaux affectant les DAPK ?\nLes habitudes alimentaires influencent-elles les DAPK ?\nLe stress a-t-il un impact sur les DAPK ?\nL'exercice physique aide-t-il les DAPK ?",
"url": "https://questionsmedicales.fr/mesh/D064550#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Death-associated protein kinases",
"description": "Existe-t-il des traitements ciblant les DAPK ?\nComment les thérapies géniques affectent-elles les DAPK ?\nLes médicaments anti-inflammatoires influencent-ils les DAPK ?\nLes DAPK sont-elles une cible pour l'immunothérapie ?\nQuels effets des traitements sur les DAPK ?",
"url": "https://questionsmedicales.fr/mesh/D064550#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Death-associated protein kinases",
"description": "Quelles complications peuvent survenir avec des DAPK dysfonctionnelles ?\nLes DAPK sont-elles liées à des complications cardiovasculaires ?\nComment les DAPK affectent-elles la réponse au traitement ?\nLes DAPK influencent-elles la résistance aux médicaments ?\nY a-t-il des complications liées à la neurodégénérescence ?",
"url": "https://questionsmedicales.fr/mesh/D064550#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Death-associated protein kinases",
"description": "Quels facteurs génétiques influencent les DAPK ?\nL'âge est-il un facteur de risque pour les DAPK ?\nLe tabagisme influence-t-il les DAPK ?\nY a-t-il des facteurs hormonaux affectant les DAPK ?\nL'exposition à des produits chimiques est-elle un risque ?",
"url": "https://questionsmedicales.fr/mesh/D064550#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des DAPK ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de protéines peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux DAPK ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de DAPK peuvent être mesurés dans les tissus tumoraux."
}
},
{
"@type": "Question",
"name": "Les DAPK sont-elles liées à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont souvent associées à des cancers et des maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des DAPK ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses de signalisation cellulaire sont courants."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les DAPK dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, la détection se fait principalement dans les tissus, pas dans le sang."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une suractivation des DAPK ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivation peut entraîner une apoptose excessive, provoquant des troubles cellulaires."
}
},
{
"@type": "Question",
"name": "Les DAPK affectent-elles le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent moduler la réponse immunitaire en influençant l'apoptose des lymphocytes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés aux DAPK ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques peuvent survenir en raison de la mort cellulaire dans le cerveau."
}
},
{
"@type": "Question",
"name": "Les DAPK sont-elles impliquées dans la douleur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à la douleur en régulant l'apoptose dans les neurones."
}
},
{
"@type": "Question",
"name": "Quels effets sur la croissance cellulaire sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une régulation anormale des DAPK peut entraîner une croissance cellulaire incontrôlée."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des DAPK ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine et un mode de vie actif peuvent aider à maintenir leur fonction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux affectant les DAPK ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut altérer l'expression des DAPK."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les DAPK ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants peut soutenir la fonction des DAPK."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les DAPK ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affecter l'expression des DAPK et induire des dysfonctionnements."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il les DAPK ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la régulation des DAPK et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Existe-t-il des traitements ciblant les DAPK ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de DAPK sont en cours de développement pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les thérapies géniques affectent-elles les DAPK ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent moduler l'expression des DAPK pour restaurer l'apoptose."
}
},
{
"@type": "Question",
"name": "Les médicaments anti-inflammatoires influencent-ils les DAPK ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent affecter l'activité des DAPK en réduisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les DAPK sont-elles une cible pour l'immunothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être ciblées pour améliorer la réponse immunitaire contre les tumeurs."
}
},
{
"@type": "Question",
"name": "Quels effets des traitements sur les DAPK ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent moduler l'expression des DAPK, influençant l'apoptose."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des DAPK dysfonctionnelles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des cancers, des maladies auto-immunes et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les DAPK sont-elles liées à des complications cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une régulation anormale peut contribuer à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment les DAPK affectent-elles la réponse au traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des DAPK dysfonctionnelles peuvent réduire l'efficacité des traitements anticancéreux."
}
},
{
"@type": "Question",
"name": "Les DAPK influencent-elles la résistance aux médicaments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des altérations des DAPK peuvent contribuer à la résistance aux médicaments anticancéreux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées à la neurodégénérescence ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des DAPK mal régulées peuvent aggraver les maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Quels facteurs génétiques influencent les DAPK ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations dans les gènes DAPK peuvent augmenter le risque de cancer."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les DAPK ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter l'expression et la fonction des DAPK."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les DAPK ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer l'expression des DAPK et augmenter le risque de cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs hormonaux affectant les DAPK ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres hormonaux peuvent influencer l'activité des DAPK."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des agents cancérigènes peut affecter les DAPK et augmenter le risque de cancer."
}
}
]
}
]
}
Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China. leethres@hotmail.com.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Institute of Materia Medical, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350122, China.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
Publications dans "Death-associated protein kinases" :
Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. xzhou@bidmc.harvard.edu.
Publications dans "Death-associated protein kinases" :
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Publications dans "Death-associated protein kinases" :
Tremendous amount of financial resources and manpower have been invested to understand the function of numerous genes that are deregulated during the carcinogenesis process, which can be targeted for ...
Death-associated protein kinase 1 (DAPK1), a Ca2+/calmodulin-regulated serine/threonine kinase, regulates cell apoptosis and autophagy and has been implicated in the pathogenesis of Alzheimer's diseas...
Death Associated Protein Kinase 1 (DAPK1) is a calcium/calmodulin-dependent serine/threonine kinase, which has been reported to be a tumor suppressor with unbalanced expression in various tissues. How...
The online GEPIA2 database was used to support TCGA results. We explored the DAPK1 pan-cancer genomic alteration analysis using the cBioPortal web tool. The Human Protein Atlas (HPA) was employed to m...
DAPK1 is aberrantly expressed in most cancer types and has prognostic power in various cancers. Gene mutation was the most common DAPK1 alteration across pan-cancers. The DAPK1 protein was mainly loca...
Our findings suggest that DAPK1 may not only be an effective prognostic factor in cancer patients but may also function as a promising predictive immunotherapy biomarker for cancer patients treated wi...
Oxidative stress plays a significant role in cataract development. It causes the apoptosis of lens epithelial cells (LECs), resulting in lens opacification and accelerating cataract progression. Long ...
Alzheimer's disease (AD) is the most prevalent form of dementia in the elderly and represents a major clinical challenge in the ageing society. Neuropathological hallmarks of AD include neurofibrillar...
Death-associated protein kinase 1 (DAPK1) is a phosphotransferase in the serine/threonine kinase family. Inhibiting DAPK1 is expected to be beneficial in treating Alzheimer's disease and protecting ne...
Protein phosphorylation plays an important role in the signal transduction and is capable of regulation of cell activity. The death-associated protein kinase 1 (DAPK1), as a Ser/Thr kinase, interacts ...
Breast cancer is one of the major malignancies in women, and most related deaths are due to recurrence, drug resistance, and metastasis. The expression of the mouse double minute 2 (MDM2) oncogene is ...
Sixteen patient-derived xenografts (PDXs) were analyzed using a mass spectrometry (MS)-based kinase inhibitor pull-down assay (KIPA), leading to the observation that death-associated protein kinase 3 ...